Torasemide (LUPRAC®): A review of its pharmacological and clinical profile

Folia Pharmacologica Japonica

Volumn 118, Issue 2, 2001, Pages 97-105

  Kido, Hideaki ^a   Ohtaki, Yutaka ^a  

^a Welfide Corporation   (Japan)

Author keywords

Aldosterone; Furosemide; Loop diuretic; Potassium sparing diuretic; Torasemide

Indexed keywords

ALDOSTERONE; FUROSEMIDE; LOOP DIURETIC AGENT; LUPRAC; SPIRONOLACTONE; TORASEMIDE; ALDOSTERONE ANTAGONIST; DIURETIC AGENT; SULFONAMIDE;

DRUG BIOAVAILABILITY; DRUG EFFECT; EDEMA; HEART DEATH; HUMAN; HYPOKALEMIA; POTASSIUM EXCRETION; REVIEW; SODIUM EXCRETION; ANIMAL; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; HEART EDEMA; MORTALITY;

ALDOSTERONE ANTAGONISTS; ANIMALS; CLINICAL TRIALS; DIURETICS; EDEMA, CARDIAC; FUROSEMIDE; HEART FAILURE, CONGESTIVE; HUMANS; HYPOKALEMIA; SULFONAMIDES;

EID: 0034897198     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.118.97     Document Type: Review

References (21)

1. Edema and principles of diuretic use
2. Diuretic complications
3. Chemistry and pharmacological properties of the pyridine-3-sulfonylurea derivative torasemide
4. Baroreflex and beta-adrenoceptor function are diminished in rat cardiac hypertrophy due to volume overload
5. Torasemide inhibits NaCl reabsorption in the thick ascending limb of the loop of Henle
6. Effects of torasemide on renal haemodynamics and function in anaesthetized dogs
7. Renal effects of torasemide in the rat. Clearance and micropuncture studies
8. Anti-aldosteronergic effect of torasemide
9. Effects of type of diuretic on mortality in patients with chronic congestive heart failure (CHF). TORIC Study
10. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
11. Pharmacokinetics and metabolism of torasemide in man
12. Torsemide: A pyridine-sulfonylurea loop diuretic
13. Comparative pharmacodynamics of torasemide and furosemide in patients with oedema
14. Comparative analysis of torasemide and furosemide in liver cirrhosis
15. Torasemide versus furosemide in cirrhosis: A long-term, double-blind, randomized clinical study
16. Comparison of therapies with torasemide or furosemide in patients with congestive heart failure from a pharmacoeconomic viewpoint
17. Healthcare costs of patients with heart failure treated with torasemide or furosemide